FCSC - Fibrocell Science Inc

Industry: Drugs - Generic Sector: Healthcare Exchange: NYSE

FCSC - Fibrocell Science Inc

Industry: Drugs - Generic Sector: Healthcare Exchange: NYSE

Fri 19'th Oct 2018

PERIOD 2018-07-20 - 2018-10-19
CHANGE -2.01%
PRICE $1.95





Request Prediction

Fibrocell Science Inc Stock Analysis

Technical stock analysis for Fri 19'th Oct 2018

Sell candidate since 2018-10-17 Loss -2.99%
Shorts 3.39% ( 2018-09-28 )
Cash 11.9 mill
Loans n/a
Beta 1.00
ROA -21.65

Fibrocell Science Inc fell by -2.01% in the last day from $1.99 to $1.95 and has now fallen 3 days in a row. The price has fallen in 7 of the last 10 days and is down by -11.76% for this period. Volume has increased in the last day by 29 533 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 80 428 shares bought and sold for approximately $156 835.00.


Fibrocell Science Inc lies in the lower part of a very wide and weak rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $1.86 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 2.8% during the next 3 months and, with 90% probability hold a price between $1.91 and $2.44 at the end of this period.

Click here for today's Top 5 Trending Companies


There are few to none technical positive signals at the moment. Fibrocell Science Inc holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $2.13. On a fall, the stock will find some support from the short-term average at $1.94. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. A sales signal was issued from a pivot top point on Wednesday October 17, 2018, which indicates further falls until a new bottom pivot has been found. Fibrocell Science Inc gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's".

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 31 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Fibrocell Science Inc finds support from accumulated volume at $1.91.

Support: $1.91 Price: $1.95 Resistance: $2.17


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.23 between high and low, or 12.43%. For the last week, the stock has had a daily average volatility of 9.25%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High


The Fibrocell Science Inc stock holds several negative signals and despite the positive trend we believe Fibrocell Science Inc will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Sell Candidate

Click for Top 5 Sell Candidates
FCSC $1.95 $-0.04(-2.01%)
FCSC is down $0.04 today, but where's it headed in November?
Zacks Investment Research is releasing its prediction for FCSC based on the 1-3 month system that more than doubles the S&P 500.

Click here – the FCSC analysis is free »

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at

in partnership with